Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0258 Transporter Info | ||||
| Gene Name | SLC2A3 | ||||
| Protein Name | Glucose transporter type 3, brain | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs12842 | ||||
| Site of GPD | chr12:7919412 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C / T>G | ||||
| Minor Allele Frequency | T=0.0938/470 (Global) | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| N.A. | N.A. | Attention-deficit/hyperactivity disorder (ADHD) | Correlated with the risk of attention-deficit/hyperactivity disorder (compare with C) | [ 1] | |
| References | |||||
| 1 | SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2017 Jul;58(7):798-809. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.